Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

UNITEDHEALTH GROUP INC.

(UNH)
  Report
Real-time Estimate Cboe BZX  -  12:09:39 2023-02-02 pm EST
467.18 USD   -6.00%
02/01AbbVie's Humira gets a U.S. rival, but costs could stay high
RE
01/31AbbVie's Humira gets a U.S. rival, but costs could stay high
RE
01/30UnitedHealthcare Provides $750,000 Grant to Community Health Care Association of New York State To Create Program That Aims To Improve Health Equity
BU
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Valuation
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Capitalization1 278 521332 732472 941495 373464 371-
Enterprise Value (EV)1 308 214359 278495 037514 300486 834477 293
P/E ratio 20,5x21,9x27,8x25,0x21,0x18,4x
Yield 1,41%1,38%1,12%1,26%1,41%1,55%
Capitalization / Revenue 1,15x1,29x1,64x1,53x1,29x1,20x
EV / Revenue 1,27x1,40x1,72x1,59x1,35x1,23x
EV / EBITDA 13,8x14,2x18,3x16,2x13,6x12,0x
Enterprise Value (EV) / FCF 18,8x17,9x24,9x22,0x19,6x18,1x
FCF Yield 5,32%5,60%4,02%4,55%5,11%5,53%
Price to Book 4,84x5,10x6,28x6,18x5,08x4,50x
Nbr of stocks (in thousands) 947 415948 821941 851934 349934 349-
Reference price (USD) 294351502530497497
Announcement Date 01/15/202001/20/202101/19/202201/13/2023--
1 USD in Million
Previous periodNext period
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Net sales1 242 155257 141287 597324 162359 616386 600
EBITDA1 22 40525 29627 07331 83535 90439 688
Operating profit (EBIT)1 19 68522 40523 97028 43531 91635 755
Operating Margin 8,13%8,71%8,33%8,77%8,88%9,25%
Pre-Tax Profit (EBT)1 17 98120 74222 31026 34329 07932 844
Net income1 13 83915 40317 28520 12022 34125 232
Net margin 5,71%5,99%6,01%6,21%6,21%6,53%
EPS2 14,316,018,121,223,727,1
Free Cash Flow1 16 39220 12319 88923 40424 89426 407
FCF margin 6,77%7,83%6,92%7,22%6,92%6,83%
FCF Conversion 73,2%79,6%73,5%73,5%69,3%66,5%
Dividend per Share2 4,144,835,606,287,027,71
Announcement Date 01/15/202001/20/202101/19/202201/13/2023--
1 USD in Million
2 USD
Previous periodNext period
Estimates
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2
Net sales1 80 14980 33280 89482 78789 76489 724
EBITDA1 7 7387 9348 2907 8738 9058 957
Operating profit (EBIT)1 6 9507 1327 4626 8917 9087 981
Operating Margin 8,67%8,88%9,22%8,32%8,81%8,90%
Pre-Tax Profit (EBT)1 6 5176 6656 9466 2157 1817 214
Net income1 5 0275 0705 2624 7615 5225 580
Net margin 6,27%6,31%6,50%5,75%6,15%6,22%
EPS2 5,275,345,555,035,845,92
Dividend per Share2 1,451,651,651,581,641,82
Announcement Date 04/14/202207/15/202210/14/202201/13/2023--
1 USD in Million
2 USD
Previous periodNext period
Estimates
Balance Sheet Analysis
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Net Debt1 29 69326 54622 09618 92722 46212 922
Net Cash position1 ------
Leverage (Debt / EBITDA) 1,33x1,05x0,82x0,59x0,63x0,33x
Free Cash Flow1 16 39220 12319 88923 40424 89426 407
ROE (Net Profit / Equities) 25,7%24,9%24,1%25,7%26,5%27,1%
Shareholders' equity1 53 84861 85971 68778 24884 45993 086
ROA (Net Profit / Asset) 8,48%8,30%8,44%8,79%8,76%9,31%
Assets1 163 196185 589204 748228 956254 929271 157
Book Value Per Share2 60,868,880,085,797,8111
Cash Flow per Share2 19,123,123,427,632,732,8
Capex1 2 0712 0512 4542 8023 1383 434
Capex / Sales 0,86%0,80%0,85%0,86%0,87%0,89%
Announcement Date 01/15/202001/20/202101/19/202201/13/2023--
1 USD in Million
2 USD
Previous periodNext period
Estimates
Key data
Capitalization (USD) 464 371 489 281
Net sales (USD) 287 597 000 000
Number of employees 350 000
Sales / Employee (USD) 821 706
Free-Float 99,5%
Free-Float capitalization (USD) 462 149 484 286
Avg. Exchange 20 sessions (USD) 1 998 179 639
Average Daily Capital Traded 0,43%
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA